Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be eligible for and starting a specific biologic medication called guselkumab, as approved for your condition
- You must be willing to sign a consent form that allows your data to be collected and checked
- Your doctor believes you are able and willing to complete patient questionnaires throughout the study
Who may not be able to join:
- You have been treated with more than 4 different advanced therapies for inflammatory bowel disease (a condition affecting the digestive system) in the past
- You have previously used a type of medication called an IL-23 inhibitor — although if your only prior treatment of this kind was a drug called ustekinumab, you may still be eligible (confirm with trial site)
- You have had surgery to remove part or all of your large bowel, or have had a pouch created as part of bowel surgery
- You are currently taking part in another clinical trial or a separate observational study run by Janssen or Johnson & Johnson
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Janssen-Cilag G.m.b.H, Germany Clinical Trial, Janssen-Cilag G.m.b.H
Phone: 844-434-4210
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants Achieving Clinical Remission for Crohn's Disease (CD) as Measured by Harvey-Bradshaw Index (HBI); Percentage of Participants Achieving Clinical Remission for Ulcerative Colitis (UC) as Measured by Partial Mayo Score (PMS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.